Efficacy of ivabradine in heart failure patients with a high‐risk profile (analysis from the SHIFT trial)

AIMS: Early start and patient profile‐oriented heart failure (HF) management has been recommended. In this post hoc analysis from the SHIFT trial, we analysed the treatment effects of ivabradine in HF patients with systolic blood pressure (SBP) < 110 mmHg, resting heart rate (RHR) ≥ 75 b.p.m., le...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdin, Amr, Komajda, Michel, Borer, Jeffrey S., Ford, Ian, Tavazzi, Luigi, Batailler, Cécile, Swedberg, Karl, Rosano, Giuseppe M.C., Mahfoud, Felix, Böhm, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567656/
https://www.ncbi.nlm.nih.gov/pubmed/37427483
http://dx.doi.org/10.1002/ehf2.14455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567656/
https://www.ncbi.nlm.nih.gov/pubmed/37427483
http://dx.doi.org/10.1002/ehf2.14455

Ejemplares similares